BG Medicine Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BG Medicine Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0159
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BG Medicine Inc (BGM), formerly Beyond Genomics Inc is a medical device company that discovers, develops and delivers diagnostic products. The company offers diagnostis products to aid in the clinical management of heart failure and related disorders. It offers BGM Galectin-3 test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform. BGM’s BGM Galectin-3 is used in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with acute and chronic heart failure. The company caters to healthcare providers. BGM is headquartered in Waltham, Massachusetts, the US.

BG Medicine Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BG Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BG Medicine Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BG Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BG Medicine Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BG Medicine Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BG Medicine Inc, Medical Equipment, Deal Details 10
Partnerships 10
BG Medicine Enters Into Agreement With Wuhan Kindstar Diagnostics For Galectin-3 Testing 10
Equity Offering 11
BG Medicine Raises USD2.3 Million in Public Offering of Units 11
BG Medicine to Raise USD2 Million in Private Placement of Series A Preferred Stock 12
BG Medicine Raises USD10 Million in Public Offering of Shares 14
BG Medicine Completes Public Offering Of Shares For US$14 Million 15
BG Medicine Inc – Key Competitors 16
BG Medicine Inc – Key Employees 17
BG Medicine Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BG Medicine Inc, Medical Equipment, Key Facts 2
BG Medicine Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BG Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BG Medicine Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BG Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BG Medicine Inc, Deals By Market, 2012 to YTD 2018 8
BG Medicine Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BG Medicine Enters Into Agreement With Wuhan Kindstar Diagnostics For Galectin-3 Testing 10
BG Medicine Raises USD2.3 Million in Public Offering of Units 11
BG Medicine to Raise USD2 Million in Private Placement of Series A Preferred Stock 12
BG Medicine Raises USD10 Million in Public Offering of Shares 14
BG Medicine Completes Public Offering Of Shares For US$14 Million 15
BG Medicine Inc, Key Competitors 16
BG Medicine Inc, Key Employees 17

List of Figures
BG Medicine Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BG Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BG Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BG Medicine Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BG Medicine Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BG Medicine Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BG Medicine Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BG Medicine Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BG Medicine Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3D Oil Ltd (TDO):石油・ガス:M&Aディール及び事業提携情報
    Summary 3D Oil Ltd (3D Oil) is a producer and developer of oil and gas properties. The company’s products include natural gas and crude oil. It has interest in exploration permits in the offshore Gippsland and Otway Basins of South East Australia. 3D Oil's projects include T49-P located in offshore …
  • Manila Electric Company:企業の戦略・SWOT・財務情報
    Manila Electric Company - Strategy, SWOT and Corporate Finance Report Summary Manila Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Clearwater Seafoods Incorporated (CLR):企業の財務・戦略的SWOT分析
    Clearwater Seafoods Incorporated (CLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Nestle SA:企業の戦略・SWOT・財務情報
    Nestle SA - Strategy, SWOT and Corporate Finance Report Summary Nestle SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • EOG Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EOG Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EOG Resources Inc (EOG) is an independent upstream oil and gas company. The company, along with its subsidiaries, explores for, develops and produces crude oil and natural gas. EOG has operations i …
  • Bluefish Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Bluefish Pharmaceuticals AB (Bluefish Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes generic pharmaceuticals. The company offers products in the therapeutic areas of cardiovascular, central nervous system, gastrointestinal, diabetes, oncology, dermat …
  • K&H Bank Zrt:企業の戦略・SWOT・財務情報
    K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report Summary K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Standardkessel Baumgarte Holding GmbH:企業の戦略的SWOT分析
    Standardkessel Baumgarte Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Carna Biosciences Inc (4572):企業の財務・戦略的SWOT分析
    Summary Carna Biosciences Inc (Carna) is a biotechnology company that discovers and develops drugs for the treatment of cancer and inflammatory diseases. The company offers products such as kinase proteins, biotinylated kinases, substrates, assay kits, protein substrates, inactive kinases, inactive- …
  • Johnson Electric Holdings Limited (179):企業の財務・戦略的SWOT分析
    Johnson Electric Holdings Limited (179) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • SaskEnergy Inc:企業の戦略的SWOT分析
    SaskEnergy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Nisshin Seifun Group Inc:企業の戦略・SWOT・財務分析
    Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Insmed Inc (INSM):医療機器:M&Aディール及び事業提携情報
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline are bein …
  • Rengo Co Ltd:企業の戦略・SWOT・財務情報
    Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pendopharm-製薬・医療分野:企業M&A・提携分析
    Summary PendoPharm is a healthcare company that offers production and commercialization of a wide range of drugs. The company’s products comprise spans prescription drugs, over-the-counter and behind-the-counter products. Its prescription products offers drugs for therapeutic areas of gastroenterolo …
  • SRP Groupe SA (SRP):企業の財務・戦略的SWOT分析
    SRP Groupe SA (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Martinrea International Inc:企業の戦略・SWOT・財務分析
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Emera Inc.:戦略・SWOT・企業財務分析
    Emera Inc. - Strategy, SWOT and Corporate Finance Report Summary Emera Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CorEnergy Infrastructure Trust, Inc. (CORR)-石油・ガス分野:企業M&A・提携分析
    Summary CorEnergy Infrastructure Trust, Inc. (CorEnergy) is an energy infrastructure real estate investment trust. The company owns assets in the midstream and downstream US energy sectors that perform functions, such as pipelines, storage terminals, and transmission and distribution assets. Its por …
  • Seagate Technology Public Limited Company (STX):企業の財務・戦略的SWOT分析
    Seagate Technology Public Limited Company (STX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆